rescinnamine is an approved drug
Compound class:
Natural product
Comment: Rescinnamine is an angiotensin-converting enzyme (ACE) inhibitor. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
|
|
Bioactivity Comments |
As we have been unable to find affinity data for this drug to substantiate its MMOA we have not tagged a primary drug target. |